Regulation of Human Cytomegalovirus Gene Expression

Advances in Virus Research

Volumn 54, Issue C, 1999, Pages 61-128

  Fortunato, Elizabeth A ^a   Spector, Deborah H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

CELL CULTURE; CELL CYCLE; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMEDIATE EARLY GENE; METABOLISM; PATHOGENICITY; REVIEW; VIROLOGY;

CELL CYCLE; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENES, IMMEDIATE-EARLY; HUMANS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 0032623289     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)60366-8     Document Type: Article

References (254)

1. Adam, B.L., Jervey, T.Y., Kohler, C.P., Wright, G. Jr., Nelson, J.A., Stenberg, R.M., The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein. J. Virol. 69:9 (1995), 5304–5310.
2. Ahn, J.H., Hayward, G.S., The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71:6 (1997), 4599–4613.
3. Ahn, J.H., Brignole, E. 3rd., Hayward, G.S., Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol. Cell. Biol. 18:8 (1998), 4899–4913.
4. Ahn, J.H., Chiou, C.J., Hayward, G.S., Evaluation and mapping of the DNA binding and oligomerization domains of the IE2 regulatory protein of human cytomegalovirus using yeast one and two hybrid interaction assays. Gene 210:1 (1998), 25–36.
5. Ahn, K., Angulo, A., Ghazal, P., Peterson, P.A., Yang, Y., Fruh, K., Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. U.S.A. 93:20 (1996), 10990–10995.
6. Akrigg, A., Wilkinson, G.W., Oram, J.D., The structure of the major immediate early gene of human cytomegalovirus strain AD169. Virus Res. 2 (1985), 107–121.
7. Albrecht, T., Boldogh, I., Fons Abu, M., Bakar, S., Deng, C.Z., Cell activation signals and the pathogenesis of human cytomegalovirus. Intervirology 31:2–4 (1990), 68–75.
8. Albrecht, T., Fons, M.P., Boldogh Abu, I., Bakar, S., Deng, C.Z., Millinoff, D., Metabolic and cellular effects of human cytomegalovirus infection. Transplant. Proc. 23 (1991), 48–55.
9. Albrecht, T., Fons, M.P., Deng, C.Z., Boldogh, I., Increased frequency of specific locus mutation following human cytomegalovirus infection. Virology 230 (1997), 48–61.
10. Angulo, A., Suto, C., Boehm, M.F., Heyman, R.A., Ghazal, P., Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69:6 (1995), 3831–3837.
11. Angulo, A., Suto, C., Heyman, R.A., Ghazal, P., Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol. Endocrinol. 10:7 (1996), 781–793.
12. Angulo, A., Chandraratna, R.A., Le Blanc, J.F., Ghazal, P., Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J. Virol. 72:6 (1998), 4589–4600.
13. Arany, Z., Newsome, D., Oldread, E., Livingston, D.M., Eckner, R., A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (London) 374 (1995), 81–84.
14. Arlt, H., Lang, D., Gebert, S., Stamminger, T., Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J. Virol. 68 (1994), 4117–4125.
15. Baldick, C. Jr., Marchini, A., Patterson, C.E., Shenk, T., Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J. Virol. 71:6 (1997), 4400–4408.
16. Baracchini, E., Glezer, E., Fish, K., Stenberg, R.M., Nelson, J.A., Ghazal, P., An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator. Virology 188 (1992), 518–529.
17. Barry, P.A., Pratt-Lowe, E., Peterlin, B.M., Luciw, P.A., Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 64 (1990), 2932–2940.
18. Baskar, J.F., Smith, P.P., Nilaver, G., Jupp, R.A., Hoffmann, S., Peffer, N.J., Tenney, D.J., Colberg-Poley, A.M., Ghazal, P., Nelson, J.A., The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:5 (1996), 3207–3214.
19. Baskar, J.F., Smith, P.P., Ciment, G.S., Hoffmann, S., Tucker, C., Tenney, D.J., Colberg-Poley, A.M., Nelson, J.A., Ghazal, P., Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J. Virol. 70:5 (1996), 3215–3226.
20. Biegalke, B.J., Regulation of human cytomegalovirus US3 gene transcription by a cis-repressive sequence. J. Virol. 69:9 (1995), 5362–5367.
21. Biegalke, B.J., IE2 protein is insufficient for transcriptional repression of the human cytomegalovirus US3 promoter. J. Virol. 71:10 (1997), 8056–8060.
22. Biegalke, B.J., Characterization of the transcriptional repressive element of the human cytomegalovirus immediate-early US3 gene. J. Virol. 72:7 (1998), 5457–5463.
23. Biegalke, B.J., Geballe, A.P., Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus. Virology 183 (1991), 381–385.
24. Boldogh Abu, I., Bakar, S., Albrecht, T., Activation of proto-oncogenes: An immediate early event in human cytomegalovirus infection. Science 247 (1990), 561–564.
25. Boldogh Abu, I., Bakar, S., Deng, C.Z., Albrecht, T., Transcriptional activation of cellular oncogenes fos, jun and myc by human cytomegalovirus. J. Virol. 65 (1991), 1568–1571.
26. Boldogh, I., Huang, E.S., Baskar, J.F., Gergely, L., Albrecht, T., Oncogenic transformation by cellular DNA isolated from human cytomegalovirus-infected cells. Intervirology 34:2 (1992), 62–73.
27. Bonin, L.R., McDougall, J.K., Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J. Virol. 71:8 (1997), 5861–5870.
28. Boppana, S.B., Britt, W.J., Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 222:1 (1996), 293–296.
29. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., Schaffner, W., A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (Cambridge, Mass.) 41 (1985), 521–530.
30. Bresnahan, W.A., Boldogh, I., Thompson, E.A., Albrecht, T., Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224 (1996), 150–160.
31. Britt, W., Alford, C., Cytomegalovirus. Fields, B.N., Knipe, D.M., Howley, R.M., et al. (eds.) Fields Virology 3rd. ed., 1996, Lippincott-Raven, Philadelphia, 2493–2523.
32. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R., Kley, N., Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (London) 377 (1995), 646–649.
33. Caswell, R., Hagemeier, C., Chiou, C.-J., Hayward, G., Kouzarides, T., Sinclair, J., The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J. Gen. Virol. 74 (1993), 2691–2698.
34. Chan, Y.J., Tseng, W.P., Hayward, G.S., Two distinct upstream regulatory domains containing multicopy cellular transcription factor binding sites provide basal repression and inducible enhancer characteristics to the immediate-early IES (US3) promoter from human cytomegalovirus. J. Virol. 70:8 (1996), 5312–5328.
35. Chan, Y.J., Chiou, C.J., Huang, Q., Hayward, G.S., Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types. J. Virol. 70:12 (1996), 8590–8605.
36. Chang, C.-P., Malone, C.L., Stinski, M.F., A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection. J. Virol. 63 (1989), 281–290.
37. Chang, C.-P., Vesole, D.H., Nelson, J., Oldstone, M.B.A., Stinski, M.F., Identification and expression of a human cytomegalovirus early glycoprotein. J. Virol. 63 (1989), 3330–3337.
38. Chang, Y.N., Crawford, S., Stall, J., Rawlins, D.R., Jeang, K.T., Hayward, G.S., The palindromic series I repeats in the simian cytomegalovirus major immediate-early promoter behave as both strong basal enhancers and cyclic AMP response elements. J. Virol. 64:1 (1990), 264–277.
39. Chapman, B.S., Thayer, R.M., Vincent, K.A., Haigwood, N.L., Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19:14 (1991), 3979–3986.
40. Cherrington, J.M., Mocarski, E.S., Human cytomegalovirus IE1 transactivates the a promoter-enhancer via an 18 base-pair repeat element. J. Virol. 63 (1989), 1435–1440.
41. Cherrington, J.M., Khoury, E.L., Mocarski, E.S., Human cytomegalovirus IE2 negatively regulates α gene expression via a short target sequence near the transcription start site. J. Virol. 65 (1991), 887–896.
42. Chiou, C.-J., Zong, J., Waheed, I., Hayward, G.S., Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus. J. Virol. 67 (1993), 6201–6214.
43. Choi, K.S., Kim, S.-J., Kim, S., The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein. Virology 208 (1995), 450–456.
44. Chrivia, J.C., Kwok, R.P.S., Lamb, N., Hagiwara, M., Montminy, M.R., Goodman, R.H., Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature (London) 365 (1993), 855–859.
45. Colberg-Poley, A.M., Santomenna, L.D., Harlow, P.P., Benfield, P.A., Tenney, D.J., Human cytomegalovirus US3 and UL36–38 immediate-early proteins regulate gene expression. J. Virol. 66:1 (1992), 95–105.
46. Colberg-Poley, A.M., Huang, L., Soltero, V.E., Iskenderian, A.C., Schumacher, R.F., Anders, D.G., The acidic domain of pUL37x1 and gpUL37 plays a key role in transactivation of HCMV DNA replication gene promoter constructions. Virology 246:2 (1998), 400–408.
47. Compton, T., Nepomuceno, R.R., Nowlin, D.M., Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191:1 (1992), 387–395.
48. Davis, M.G., Kenney, S.C., Kamine, J., Pagano, J.S., Huang, E.-S., Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 8642–8646.
49. Depto, A.S., Stenberg, R.M., Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation. J. Virol. 66:5 (1992), 3241–3246.
50. Dittmer, D., Mocarski, E.S., Human cytomegalovirus infection inhibits G1/S transition. J. Virol. 71 (1997), 1629–1634.
51. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C. Jr., Butel, J.S., Bradley, A., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (London) 356 (1992), 215–221.
52. Dutta, A., Ruppert, J.M., Aster, J.C., Winchester, E., Inhibition of DNA replication factor RPA by p53. Nature (London) 365 (1993), 79–82.
53. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression. Cell (Cambridge, Mass.) 75 (1993), 817–825.
54. Everett, R.D., A detailed analysis of an HSV-1 early promoter: Sequences involved in transactivation by viral immediate-early gene products are not early-gene specific. Nucleic Acids Res. 12 (1984), 3037–3056.
55. Fortunato, E.A., Spector, D.H., P53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J. Virol. 72:3 (1998), 2033–2039.
56. Fortunato, E.A., Sommer, M.H., Yoder, K., Spector, D.H., Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J. Virol. 71:11 (1997), 8176–8185.
57. Furnari, B.A., Poma, E., Kowalik, T.F., Huong, S.-M., Huang, E.-S., Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J. Virol. 67 (1993), 4981–4991.
58. Furth, P.A., Hennighausen, L., Baker, C., Beatty, B., Woychick, R., The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 19:22 (1991), 6205–6208.
59. Gebert, S., Schmolke, S., Sorg, G., Floss, S., Plachter, B., Stamminger, T., The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication. J. Virol. 71:9 (1997), 7048–7060.
60. Ghazal, P., Nelson, J.A., Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter. J. Virol. 65 (1991), 2299–2307.
61. Ghazal, P., Young, J., Giuletti, E., DeMattei, C., Garcia, J., Gaynor, R., Stenberg, R.M., Nelson, J.A., A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J. Virol. 65 (1991), 6735–6742.
62. Ghazal, P., DeMattei, C., Giulietti, E., Kliewer, S.A., Umesono, K., Evans, R.M., Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 7630–7634.
63. Gibson, W., Immediate-early proteins of human cytomegalovirus strains AD169, Davis, and Towne differ in electrophoretic mobility. Virology 112 (1981), 350–354.
64. Gibson, W., Synthesis, structure, and function of cytomegalovirus major nonvirion nuclear protein. UCLA Symp. Mol. Biol. 21 (1984), 423–440.
65. Gibson, W., Murphy, T., Roby, C., Cytomegalovirus-infected cells contain a DNA-binding protein. Virology 111 (1981), 251–262.
66. Gilbert, M.J., Riddell, S.R., Plachter, B., Greenberg, P.D., Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature (London) 383 (1996), 720–722.
67. Gottlieb, T.M., Oren, M., P53 in growth control and neoplasia. Biochim. Biophys. Acta. 1287:2–3 (1996), 77–102.
68. Greaves, R.F., Mocarski, E.S., Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72:1 (1998), 366–379.
69. Greaves, R.F., Brown, J.M., Vieira, J., Mocarski, E.S., Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J. Gen. Virol. 76:Pt. 9 (1995), 2151–2160.
70. Hagemeier, C., Walker, S., Caswell, R., Kouzarides, T., Sinclair, J., The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J. Virol. 66 (1992), 4452–4456.
71. Hagemeier, C., Caswell, R., Hayhurst, G., Sinclair, J., Kouzarides, T., Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13 (1994), 2897–2903.
72. Harel, N.Y., Alwine, J.C., Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2. J. Virol. 72:7 (1998), 5481–5492.
73. Hayhurst, G.P., Bryant, L.A., Caswell, R.C., Walker, S.M., Sinclair, J.H., CCAAT box-dependent activation of the TATA-less human DNA polymerase a promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. J. Virol. 69 (1995), 182–188.
74. Hennighausen, L., Fleckenstein, B., Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J. 5 (1986), 1367–1371.
75. Hermiston, T.W., Malone, C.L., Witte, P.R., Stinski, M.F., Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter. J. Virol. 61 (1987), 3214–3221.
76. Hermiston, T.W., Malone, C.L., Stinski, M.F., Human cytomegalovirus immediate-early two-protein region involved in negative regulation of the major immediate-early promoter. J. Virol. 64 (1990), 3532–3536.
77. Hiebert, S.W., Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13 (1993), 3384–3391.
78. Hill, C.S., Treisman, R., Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell (Cambridge, Mass.) 8:2 (1995), 199–211.
79. Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I., Weinberg, R.A., Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (Cambridge, Mass.) 70 (1992), 993–1006.
80. Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C.C., P53 mutations in human cancers. Science 253 (1991), 49–53.
81. Huang, H., Yee, J., Shew, J., Chen, P., Bookstein, R., Friedmann, T., Lee, E., Lee, W., Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242 (1988), 1563–1566.
82. Huang, L., Stinski, M.F., Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter. J. Virol. 69 (1995), 7612–7621.
83. Huang, L., Malone, C.L., Stinski, M.F., A human cytomegalovirus early promoter with upstream negative and positive cis-acting elements: IE2 negates the effect of the negative element, and NF-Y binds to the positive element. J. Virol. 68 (1994), 2108–2117.
84. Huang, T.H., Oka, T., Asai, T., Okada, T., Merrills, B.W., Gertson, P.N., Whitson, R.H., Itakura, K., Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. Nucleic Acids Res. 24:9 (1996), 1695–1701.
85. Hunnighake, G.W., Monick, M.M., Liu, B., Stinski, M.F., The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J. Virol. 63 (1989), 3026–3033.
86. Hunter, T., Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell (Cambridge, Mass.) 80:2 (1995), 225–236.
87. Ishov, A.M., Maul, G.G., The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134:4 (1996), 815–826.
88. Ishov, A.M., Stenberg, R.M., Maul, G.G., Human cytomegalovirus immediate early interaction with host nuclear structures: Definition of an immediate transcript environment. J. Cell Biol. 138:1 (1997), 5–16.
89. Iskenderian, A.C., Huang, L., Reilly, A., Stenberg, R.M., Anders, D.G., Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J. Virol. 70 (1996), 383–392.
90. Jahn, G., Knust, E., Schmolla, H., Sarre, T., Nelson, J.A., McDougall, J.K., Fleckenstein, B., Predominant immediate-early transcripts of human cytomegalovirus AD169. J. Virol. 49 (1984), 363–370.
91. Jahn, G., Nelson, J.A., Plachter, B., McDougall, J.K., Fleckenstein, B., Transcription of a human cytomegalovirus DNA region which is capable of transforming rodent cells. UCLA Symp. Mol. Cell. Biol. 21 (1984), 455–463.
92. Jault, F.M., Jault, J.-M., Ruchti, F., Fortunato, E.A., Clark, C., Corbeil, J., Richman, D.D., Spector, D.H., Cytomegalovirus infection induces high levels of cyclins, phosphorylated RB, and p53, leading to cell cycle arrest. J. Virol. 69 (1995), 6697–6704.
93. Jeang, K.-T., Rawlins, D.R., Rosenfeld, P.J., Shero, J.H., Kelly, T.J., Hayward, G.S., Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus. J. Virol. 61 (1987), 1559–1570.
94. Jenkins, D.E., Martens, C.L., Mocarski, E.S., Human cytomegalovirus late protein encoded by ie2: A transactivator as well as a repressor of gene expression. J. Gen. Virol. 75 (1994), 2337–2348.
95. Jones, T.R., Muzithras, V.P., A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family. J. Virol. 66:4 (1992), 2541–2546.
96. Jones, T.R., Wiertz, E.J., Sun, L., Fish, K.N., Nelson, J.A., Ploegh, H.L., Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. U.S.A. 93:21 (1996), 11327–11333.
97. Jupp, R., Hoffmann, S., Depto, A., Stenberg, R.M., Ghazal, P., Nelson, J.A., Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J. Virol. 67 (1993), 5595–5604.
98. Jupp, R., Hoffmann, S., Stenberg, R.M., Nelson, J.A., Ghazal, P., Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J. Virol. 67 (1993), 7539–7546.
99. Juven, T., Barak, Y., Zauberman, A., George, D.L., Oren, M., Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8:12 (1993), 3411–3416.
100. Kari, B., Gehrz, R., Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II. J. Gen. Virol. 74:Pt. 2 (1993), 255–264.
101. Karin, M., Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell Biol. 6:3 (1994), 415–424.
102. Kastan, M.B., Zhan, Q., el-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B., Fornace, A. Jr., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell (Cambridge, Mass.) 71:4 (1992), 587–597.
103. Keay, S., Merigan, T.C., Rasmussen, L., Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 86:24 (1989), 10100–10103.
104. Kelly, C., Van Driel, R., Wilkinson, G.W., Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J. Gen. Virol. 76:Pt. 11 (1995), 2887–2893.
105. Kerry, J.A., Priddy, M.A., Stenberg, R.M., Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products. J. Virol. 68 (1994), 4167–4176.
106. Kerry, J.A., Sehgal, A., Barlow, S.W., Cavanaugh, V.J., Fish, K., Nelson, J.A., Stenberg, R.M., Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region. J. Virol. 69 (1995), 3868–3872.
107. Kerry, J.A., Priddy, M.A., Jervey, T.Y., Kohler, C.P., Staley, T.L., Vanson Jones, C.D.T.R., Iskenderian, A.C., Anders, D.G., Stenberg, R.M., Multiple regulatory events influence expression of human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J. Virol. 70 (1996), 373–382.
108. Kerry, J.A., Priddy, M.A., Staley, T.L., Jones, T.R., Stenberg, R.M., The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection. J. Virol. 71:3 (1997), 2120–2126.
109. Klucher, K.M., Rabert, D.K., Spector, D.H., Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene. J. Virol. 63 (1989), 5334–5343.
110. Klucher, K.M., Sommer, M., Kadonaga, J.T., Spector, D.H., In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. Mol. Cell. Biol. 13 (1993), 1238–1250.
111. Ko, L.J., Prives, C., P53: Puzzle and paradigm. Genes Dev. 10:9 (1996), 1054–1072.
112. Koedood, M., Fichtel, A., Meier, P., Mitchell, P.J., Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J. Virol. 69:4 (1995), 2194–2207.
113. Kohler, C.P., Kerry, J.A., Carter, M., Muzithras, V.Z., Jones, T.R., Stenberg, R.M., Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J. Virol. 68 (1994), 6589–6597.
114. Kollert-Jons, A., Bogner, E., Radsak, K., A 15-kilobase-pair region of the human cytomegalovirus genome which includes US1 through US13 is dispensable for growth in cell culture. J. Virol. 65:10 (1991), 5184–5189.
115. Korioth, F., Maul, G.G., Plachter, B., Stamminger, T., Frey, J., The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229:1 (1996), 155–158.
116. Kothari, S., Baillie, J., Sissons, J.G., Sinclair, J.H., The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res. 19:8 (1991), 1767–1771.
117. Kouzarides, T., Bankier, A.T., Satchwell, A.C., Preddy, E., Barrell, B.G., An immediate early gene of human cytomegalovirus encodes a potential membrane glycoprotein. Virology 165 (1988), 151–164.
118. KB activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 1107–1111.
119. Kwok, R.P.S., Lundblad, J.R., Chrivia, J.C., Richards, J.P., Bachinger, H.P., Brennan, R.G., Roberts, S.G.E., Green, M.R., Goodman, R.H., Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (London) 370 (1994), 223–226.
120. La Femina, R., Hayward, G.S., Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells. J. Virol. 58:2 (1986), 434–440.
121. Lang, D., Stamminger, T., The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J. Virol. 67 (1993), 323–331.
122. Lang, D., Stamminger, T., Minor groove contacts are essential for an interaction of the human cytomegalovirus IE2 protein with its DNA target. Nucleic Acids Res. 22 (1994), 3331–3338.
123. Lang, D., Fickenscher, H., Stamminger, T., Analysis of proteins binding to the proximal promoter region of the human cytomegalovirus IE-1/2 enhancer/promoter reveals both consensus and aberrant recognition sequences for transcription factors Sp1 and CREB. Nucleic Acids Res. 20:13 (1992), 3287–3295.
124. Lang, D., Gebert, S., Arlt, H., Stamminger, T., Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J. Virol. 69 (1995), 6030–6037.
125. Lashmit, P.E., Stinski, M.F., Murphy, E.A., Bullock, G.C., A cis repression sequence adjacent to the transcription start site of the human cytomegalovirus US3 gene is required to down regulate gene expression at early and late times after infection. J. Virol. 72 (1998), 9575–9584.
126. Lee, G., Wu, J., Luu, P., Ghazal, P., Flores, O., Inhibition of the association of RNA polymerase II with the preinitiation complex by a viral transcriptional repressor. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 2570–2575.
127. Lin, R., Heylbroeck, C., Pitha, P.M., Hiscott, J., Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:5 (1998), 2986–2996.
128. Liu, B., Stinski, M.F., Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:7 (1992), 4434–4444.
129. Liu, B., Hermiston, T.W., Stinski, M.F., A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2. J. Virol. 65 (1991), 897–903.
130. Liu, R., Baillie, J., Sissons, J.G., Sinclair, J.H., The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Res. 22:13 (1994), 2453–2459.
131. Lu, M., Shenk, T., Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J. Virol. 70 (1996), 8850–8857.
132. Lubon, H., Ghazal, P., Hennighausen, L., Reynolds-Kohler, C., Lockshin, C., Nelson, J., Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol. Cell. Biol. 9 (1989), 1342–1345.
133. Lukac, D.M., Manuppello, J.R., Alwine, J.C., Transcriptional activation by the human cytomegalovirus immediate-early proteins: Requirements for simple promoter structures and interactions with multiple components of the transcription complex. J. Virol. 68 (1994), 5184–5193.
134. Lukac, D.M., Harel, N.Y., Tanese, N., Alwine, J.C., TAF-like functions of human cytomegalovirus immediate-early proteins. J. Virol. 71:10 (1997), 7227–7239.
135. Lundblad, J.R., Kwok, R.P.S., Laurance, M.E., Harter, M.L., Goodman, R.H., Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature (London) 374 (1995), 85–88.
136. Luu, P., Flores, O., Binding of SP1 to the immediate-early protein-responsive element of the human cytomegalovirus DNA polymerase promoter. J. Virol. 71:9 (1997), 6683–6691.
137. Macias, M.P., Stinski, M.F., An in vitro system for human cytomegalovirus immediate early 2 protein (IE-2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate-early promoter. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 707–711.
138. Macias, M.P., Huang, L., Lashmit, P.E., Stinski, M.F., Cellular or viral protein binding to a cytomegalovirus promoter transcription initiation site: Effects on transcription. J. Virol. 70:6 (1996), 3628–3635.
139. Malone, C.L., Vesole, D.H., Stinski, M.F., Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins. J. Virol. 64 (1990), 1498–1506.
140. Margolis, M.J., Panjovic, S., Wong, E.L., Wade, M., Jupp, R., Nelson, J.A., Azizkhan, J.C., Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol. 69 (1995), 7759–7767.
141. Marshall, C.J., Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell (Cambridge, Mass.) 80:2 (1995), 179–185.
142. Martinez, J., Lahijani, R.S., St. Jeor, S.C., Analysis of a region of the human cytomegalovirus (AD 160) genome coding for a 25-kilodalton virion protein. J. Virol. 63 (1989), 233–241.
143. Maul, G.G., Guldner, H.H., Spivack, J.G., Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74:Pt. 12 (1993), 2679–2690.
144. Maul, G.G., Ishov, A.M., Everett, R.D., Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217:1 (1996), 67–75.
145. McDonough, S.H., Spector, D.H., Transcription in human fibroblasts permissively infected by human cytomegalovirus strain AD169. Virology 125 (1983), 31–46.
146. McDonough, S.H., Staprans, S.I., Spector, D.H., Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169. J. Virol. 53 (1985), 711–718.
147. + virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43:1 (1994), 103–110.
148. Meier, J.L., Stinski, M.F., Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. J. Virol. 71:2 (1997), 1246–1255.
149. Michelson, S., Turowski, P., Picard, L., Goris, J., Landini, M.P., Topilko, A., Hemmings, B., Bessia, C., Garcia, A., Virelizier, J.L., Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J. Virol. 70:3 (1996), 1415–1423.
150. Miller, S.D., Moses, K., Jayaraman, L., Prives, C., Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single-stranded DNA. Mol. Cell. Biol. 17:4 (1997), 2194–2201.
151. Miyashita, T., Reed, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (Cambridge, Mass.) 80:2 (1995), 293–299.
152. Mocarski, E.S., Cytomegaloviruses and their replication. Fields, B.N., Knipe, D.M., Wley, P.M.H., et al. (eds.) Field's Virology 3rd ed., 1996, Lippincott-Raven, Philadelphia, 2447–2492.
153. Muganda, P., Mendoza, O., Hernandez, J., Qian, Q., Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J. Virol. 68 (1994), 8028–8034.
154. Navarro, L., Mowen, K., Rodems, S., Weaver, B., Reich, N., Spector, D., David, M., Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol. Cell. Biol. 18:7 (1998), 3796–3802.
155. Nelson, J.A., Groudine, M., Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol. Cell. Biol. 6:2 (1986), 452–461.
156. Nelson, J.A., Reynolds-Kohler, C., Smith, B.A., Negative and positive regulation by a short segment in the 5′ flanking region of the human cytomegalovirus major immediate early gene. Mol. Cell. Biol. 7 (1987), 4125–4129.
157. Niller, H.H., Hennighausen, L., Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP. J. Virol. 64:5 (1990), 2388–2391.
158. Okamoto, K., Beach, D., Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13:20 (1994), 4816–4822.
159. Pajovic, S., Wong, E.L., Black, A.R., Azizkhan, J.C., Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol. Cell. Biol. 17:11 (1997), 6459–6464.
160. Pari, G.S., Anders, D.G., Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol. 67 (1993), 6979–6988.
161. Pari, G.S., Kacica, M.A., Anders, D.G., Open reading frames UL44, IRS1/ TRS1, and UL36–38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J. Virol. 67:5 (1993), 2575–2582.
162. Pari, G.S., Field, A.K., Smith, J.A., Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37. Antimicrob. Agents Chemother. 39:5 (1995), 1157–1161.
163. Paya, C.V., Virelizier, J.-L., Michelson, S., Modulation of T-cell activation through protein kinase C- or A-dependent signaling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate-early proteins. J. Virol. 65 (1991), 5477–5484.
164. Pende, M., Fisher, T.L., Simpson, P.B., Russell, J.T., Blenis, J., Gallo, V., Neurotransmitter- and growth factor-induced cAMP response element binding protein phosphorylation in glial cell progenitors: role of calcium ions, protein kinase C, and mitogen-activated protein kinase/ribosomal S6 kinase pathway. J. Neurosci. 17:4 (1997), 1291–1301.
165. Penfold, M.E., Mocarski, E.S., Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology 239:1 (1997), 46–61.
166. Pietropaolo, R.L., Compton, T., Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II. J. Virol. 71:12 (1997), 9803–9807.
167. Pizzorno, M.C., Hayward, G.S., The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site. J. Virol. 64 (1990), 6154–6165.
168. Pizzorno, M.C., O'Hare, P., Sha, L., La Femina, R.L., Hayward, G.S., Transactivation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus. J. Virol. 62 (1988), 1167–1179.
169. Pizzorno, M.C., Mullen, M.-A., Chang, Y.-N., Hayward, G.S., The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal. J. Virol. 65 (1991), 3839–3852.
170. Plachter, B., Traupe, B., Albrecht, J., Jahn, G., Abundant 5 kb RNA of human cytomegalovirus without a major translational reading frame. J. Gen. Virol. 69 (1988), 2251–2266.
171. Poma, E.E., Kowalik, T.F., Zhu, L., Sinclair, J.H., Huang, E.S., The human cytomegalovirus IE1–72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 70:11 (1996), 7867–7877.
172. Puchtler, E., Stamminger, T., An inducible promoter mediates abundant expression from the immediate-early 2 gene region of human cytomegalovirus at late times after infection. J. Virol. 65 (1991), 6301–6303.
173. Qian, Y., Luckey, C., Horton, L., Esser, M., Templeton, D.J., Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol. Cell. Biol. 12 (1992), 5363–5372.
174. Qin, X.-Q., Chittenden, T., Livingston, D.M., Kaelin, W.G. Jr., Identification of the growth suppressor dorain within the retinoblastoma gene product. Genes Dev. 6 (1992), 953–964.
175. Rando, R.F., Srinivasan, A., Feingold, J., Gönczöl, E., Plotkin, S., Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology 176 (1990), 87–97.
176. Rasmussen, R. D. (1988). Characterization of the late transcripts and viral DNA from a region of HCMV which contains cell-related sequences. Ph.D. Thesis, University of California, San Diego, La Jolla.
177. Rodems, S.M., Clark, C.L., Spector, D.H., Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112–113 promoter at early and late times in the infection. J. Virol. 72:4 (1998), 2697–2707.
178. Romanowski, M.J., Shenk, T., Characterization of the human cytomegalovirus irs1 and trs1 genes: A second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J. Virol. 71:2 (1997), 1485–1496.
179. Romanowski, M.J., Garrido-Guerrero, E., Shenk, T., PIRS1 and pTRS1 are present in human cytomegalovirus virions. J. Virol. 71:7 (1997), 5703–5705.
180. Salvant, B.S., Fortunato, E.A., Spector, D.H., Cell cycle dysregulation by human cytomegalovirus: Influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J. Virol. 72:5 (1998), 3729–3741.
181. KB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8 (1989), 4251–4258.
182. Sarisky, R.T., Hayward, G.S., Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays. J. Virol. 70:11 (1996), 7398–7413.
183. Schafer, S.L., Lin, R., Moore, P.A., Hiscott, J., Pitha, P.M., Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273:5 (1998), 2714–2720.
184. Schmidt, E.V., Christoph, G., Zeller, R., Leder, P., The cytomegalovirus enhancer: A pan-active control element in transgenic mice. Mol. Cell. Biol. 10:8 (1990), 4406–4411.
185. Schwartz, R., Sommer, M.H., Scully, A., Spector, D.H., Site-specific binding of the human cytomegalovirus IE2 86-Kilodalton protein to an early gene promoter. J. Virol. 68 (1994), 5613–5622.
186. Schwartz, R., Helmich, B., Spector, D.H., CREB and CREB-binding proteins play an important role in the IE2 86-mediated transactivation of the human cytomegalovirus 2.2-kb RNA promoter. J. Virol. 70 (1996), 6955–6966.
187. Scully, A.L., Sommer, M.H., Schwartz, R., Spector, D.H., The human cytomegalovirus IE2 86 kDa protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations. J. Virol. 69 (1995), 6533–6540.
188. Shelbourn, S.L., Kothari, S.K., Sissons, J.G., Sinclair, J.H., Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. Nucleic Acids Res. 17:22 (1989), 9165–9171.
189. Shen, Y., Zhu, H., Shenk, T., Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc. Natl. Acad. Sci. U.S.A. 94 (1997), 3341–3345.
190. Sinclair, J.H., Baillie, J., Bryant, L.A.A.T.-J., Sissons, J.G., Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. J. Gen. Virol. 73 (1992), 433–435.
191. Sinzger, C., Jahn, G., Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39:5–6 (1996), 302–319.
192. Smith, J.A., Pari, G.S., Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication. J. Virol. 69:3 (1995), 1925–1931.
193. Sommer, M.H., Scully, A.L., Spector, D.H., Trans-activation by the human cytomegalovirus IE2 86 kDa protein requires a domain that binds to both TBP and RB. J. Virol. 68 (1994), 6223–6231.
194. Somogyi, T., Michelson, S., Masse, M.J., Genomic location of a human cytomegalovirus protein with protein kinase activity (PK68). Virology 174:1 (1990), 276–285.
195. Spector, D.J., Tevethia, M.J., Protein-protein interactions between human cytomegalovirus IE2–580aa and pUL84 in lytically infected cells. J. Virol. 68 (1994), 7549–7553.
196. Speir, E., Modali, R., Huang, E.-S., Leon, M.B., Sahwl, F., Finkel, T., Epstein, S.E., Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265 (1994), 391–394.
197. Spiller, O.B., Borysiewicz, L.K., Morgan, B.P., Development of a model for cytomegalovirus infection of oligodendrocytes. J. Gen. Virol. 78:Pt. 12 (1997), 3349–3356.
198. Staprans, S.I., Spector, D.H., 2.2-Kilobase class of early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD 169. J. Virol. 57 (1986), 591–602.
199. Staprans, S.I., Rabert, D.K., Spector, D.H., Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J. Virol. 62 (1988), 3463–3473.
200. Stasiak, P.C., Mocarski, E.S., Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to the IE1 and IE2. J. Virol. 66 (1992), 1050–1058.
201. Stenberg, R.M., Thomsen, D.R., Stinski, M.F., Structural analysis of the major immediate early gene of human cytomegalovirus. J. Virol. 49 (1984), 190–199.
202. Stenberg, R.M., Witte, P.R., Stinski, M.F., Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J. Virol. 56 (1985), 665–675.
203. Stenberg, R.M., Depto, A.S., Fortney, J., Nelson, J.A., Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J. Virol. 63 (1989), 2699–2708.
204. Stenberg, R.M., Fortney, J., Barlow, S.W., Magrane, B.P., Nelson, J.A., Ghazal, P., Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J. Virol. 64 (1990), 1556–1565.
205. Stinski, M.F., Thomsen, D.R., Stenberg, R.M., Goldstein, L.C., Organization and expression of the immediate-early genes of human cytomegalovirus. J. Virol. 46 (1983), 1–14.
206. Sturzbecher, H.W., Donzelmann, B., Henning, W., Knippschild, U., Buchhop, S., P53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15:8 (1996), 1992–2002.
207. Taya, Y., RB kinases and RB-binding proteins: New points of view. Trends Biochem. Sci. 22 (1997), 14–17.
208. Taylor, H.P., Cooper, N.R., Human cytomegalovirus binding to fibroblasts is receptor mediated. J. Virol. 63:9 (1989), 3991–3998.
209. Taylor, H.P., Cooper, N.R., The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein. J. Virol. 64:6 (1990), 2484–2490.
210. Templeton, D.J., Park, S.H., Lanier, L., Weinberg, R.A., Non-functional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association and nuclear tethering. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 3033–3039.
211. Tenney, D.J., Colberg-Poley, A.M., Expression of the human cytomegalovirus UL36–38 immediate early region during permissive infection. Virology 182 (1991), 199–210.
212. Tenney, D.J., Colberg-Poley, A.M., Human cytomegalovirus UL36–38 and US3 immediate-early genes: Temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J. Virol. 65 (1991), 6724–6734.
213. Tenney, D.J., Santomenna, L.D., Goudie, K.B., Colberg-Poley, A.M., The human cytomegalovirus US3 immediate-early protein lacking the putative transmembrane domain regulates gene expression. Nucleic Acids Res. 21:12 (1993), 2931–2937.
214. Tevethia, M.J., Spector, D.J., Leisure, K.M., Stinski, M.F., Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters. Virology 161 (1987), 276–285.
215. Thanos, D., Maniatis, T., NF-kappa B: A lesson in family values. Cell (Cambridge, Mass.) 80:4 (1995), 529–532.
216. Thomsen, D.R., Stenberg, R.M., Goins, W.F., Stinski, M.F., Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 81 (1984), 659–663.
217. Thrower, A.R., Bullock, G.C., Bissell, J.E., Stinski, M.F., Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination. J. Virol. 70:1 (1996), 91–100.
218. Topilko, A., Michelson, S., Hyperimmediate entry of human cytomegalovirus virions and dense bodies into human fibroblasts. Res. Virol. 145:2 (1994), 75–82.
219. Wade, E.J., Klucher, K.M., Spector, D.H., An AP-1 binding site is the predominant cis-acting regulatory element in the 1.2 kilobase early RNA promoter of human cytomegalovirus. J. Virol. 66 (1992), 2407–2417.
220. Walker, S., Hagemeier, C., Sissons, J.G.P., Sinclair, J.H., A 10–base pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in transactivation by the 80-kilodalton IE2 protein. J. Virol. 66 (1992), 1543–1550.
221. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., Riddell, S.R., Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:16 (1995), 1038–1044.
222. Wang, J.Y., Retinoblastoma protein in growth suppression and death protection. Curr. Opin. Genet. Dev. 7 (1997), 39–45.
223. Wang, J.Y.J., Knudsen, E.S., Welch, P.J., The retinoblastoma tumor suppressor protein. Adv. Cancer. Res. 64 (1994), 25–85.
224. Wang, X.W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.M., Wang, Z., Freidberg, E.C., Evans, M.K., Taffe, B.G., Bohr, V.A., Weeda, G., Hoeijmakers, J.H.J., Forrester, K., Harris, C.C., P53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10:2 (1995), 188–195.
225. Wathelet, M.G., Lin, C.H., Parekh, B.S., Ronco, L.V., Howley, P.M., Maniatis, T., Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1:4 (1998), 507–518.
226. Wathen, M.W., Stinski, M.F., Temporal patterns of human cytomegalovirus transcription: Mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J. Virol. 41 (1982), 462–477.
227. Wathen, M.W., Thomsen, D.R., Stinski, M.F., Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection. J. Virol. 38 (1981), 446–459.
228. Weaver, B.K., Kumar, K.P., Reich, N.C., Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18:3 (1998), 1359–1368.
229. Weinberg, R.A., The retinoblastoma protein and cell cycle control. Cell (Cambridge, Mass.) 81 (1995), 323–330.
230. Weston, K., An enhancer element in the short unique region of human cytomegalovirus regulates the production of a group of abundant immediate early transcripts. Virology 162:2 (1988), 406–416.
231. Weston, K., Barrell, B.G., Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus. J. Mol. Biol. 192 (1986), 177–208.
232. Wilkinson, G.W.G., Akrigg, A., Greenaway, P.J., Transcription of immediate early genes of human cytomegalovirus strain AD169. Virus Res. 1 (1984), 101–116.
233. Wills, M.R., Carmichael, A.J., Mynard, K., Jin, X., Weekes, M.P., Plachter, B., Sissons, J.G., The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70:11 (1996), 7569–7579.
234. Wing, B.A., Huang, E.S., Analysis and mapping of a family of 3′-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J. Virol. 69:3 (1995), 1521–1531.
235. Wing, B.A., Lee, G.C., Huang, E.S., The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J. Virol. 70:6 (1996), 3339–3345.
236. Wing, B.A., Johnson, R.A., Huang, E.S., Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: Role of IE2–86 and cellular p53 in mediating negative regulatory function. J. Virol. 72:3 (1998), 1814–1825.
237. Winkler, M., Stamminger, T., A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J. Virol. 70:12 (1996), 8984–8987.
238. Winkler, M.S., Rice, S.A., Stamminger, T., UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J. Virol. 68 (1994), 3943–3954.
239. Wright, D.A., Spector, D.H., Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit. J. Virol. 63 (1989), 3117–3127.
240. Wright, D.A., Staprans, S.I., Spector, D.H., Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD 169. J. Virol. 62 (1988), 331–340.
241. Wright, J.F., Kurosky, A., Wasi, S., An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun. 198:3 (1994), 983–989.
242. Wright, J.F., Kurosky, A., Pryzdial, E.L., Wasi, S., Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J. Virol. 69:8 (1995), 4784–4791.
243. Wu, J., Jupp, R., Stenberg, R.M., Nelson, J.A., Ghazal, P., Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein. J. Virol. 67 (1993), 7547–7555.
244. Wu, J., O'Neill, J., Barbosa, M.S., Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells. J. Virol. 72:1 (1998), 236–244.
245. Xing, J., Ginty, D.D., Greenberg, M.E., Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273 (1996), 959–963.
246. Xing, J., Kornhauser, J.M., Xia, Z., Thiele, E.A., Greenberg, M.E., Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18 (1998), 1946–1955.
247. Yamamoto, K.K., Gonzalez, G.A., Menzel, P., Rivier, J., Montminy, M.R., Characterization of a bipartite activator domain in transcription factor CREB. Cell (Cambridge, Mass.) 60 (1990), 611–617.
248. Yeung, K.C., Stoltzfus, C.M., Stinski, M.F., Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter. Virology 63 (1993), 1435–1440.
249. Yoo, Y.D., Chiou, C.J., Choi, K.S., Yi, Y., Michelson, S., Kim, S., Hayward, G.S., Kim, S.J., The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site. J. Virol. 70:10 (1996), 7062–7070.
250. Yurochko, A.D., Kowalik, T.F., Huong, S.M., Huang, E.S., Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/ p50 and p65 promoters. J. Virol. 69:9 (1995), 5391–5400.
251. Yurochko, A.D., Hwang, E.S., Rasmussen, L., Keay, S., Pereira, L., Huang, E.S., The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J. Virol. 71:7 (1997), 5051–5059.
252. Zhang, H., al-Barazi, H.O., Colberg-Poley, A.M., The acidic domain of the human cytomegalovirus UL37 immediate early glycoprotein is dispensable for its transactivating activity and localization but is not for its synergism. Virology 223:2 (1996), 292–302.
253. Zhu, H., Cong, J.P., Shenk, T., Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. U.S.A. 94:25 (1997), 13985–13990.
254. Zhu, H., Cong, J.P., Mamtora, G., Gingeras, T., Shenk, T., Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95:24 (1998), 14470–14475.